中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [36]
心理研究所 [3]
上海天文台 [2]
紫金山天文台 [2]
计算技术研究所 [1]
过程工程研究所 [1]
更多
采集方式
OAI收割 [46]
内容类型
期刊论文 [46]
发表日期
2024 [3]
2023 [2]
2022 [6]
2019 [6]
2018 [9]
2017 [6]
更多
学科主题
筛选
浏览/检索结果:
共46条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Cellular vesicles-based "all-in-one" vaccine platform triggers mucosal immunity against respiratory viruses
期刊论文
OAI收割
NANO TODAY, 2024, 卷号: 59, 页码: 12
作者:
Gao, Yanrong
;
Zhu, Jie
;
Zhai, Jimao
;
Ou, Ante
;
Fan, Baoru
  |  
收藏
  |  
浏览/下载:14/0
  |  
提交时间:2024/10/21
Inhaled vaccine
Cell membrane vesicles
Respiratory viruses
CpG
SARS-CoV-2
Heparin-Conjugated ACE2-Bearing Extracellular Vesicles As Engineered Dual-Decoy for Combating the SARS-CoV-2 Omicron Variant via Pulmonary Delivery
期刊论文
OAI收割
ACS MATERIALS LETTERS, 2024, 页码: 9
作者:
Tu, Bin
;
Pan, Zhenzhen
;
Wang, Huiyuan
;
Qu, Jingkun
;
Sun, Feifei
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2024/05/07
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
期刊论文
OAI收割
PHARMACEUTICS, 2024, 卷号: 16, 期号: 1, 页码: 28
作者:
Kang, Xuejia
;
Huang, Yongzhuo
;
Wang, Huiyuan
;
Jadhav, Sanika
;
Yue, Zongliang
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2024/02/27
tumor-associated macrophage
suppressive immune environment
tumor proliferation and metastasis
nanomedicine
targeted delivery systems
Cell penetrating peptides: Highlighting points in cancer therapy
期刊论文
OAI收割
DRUG DEVELOPMENT RESEARCH, 2023, 页码: 35
作者:
Asrorov, Akmal M.
;
Wang, Huiyuan
;
Zhang, Meng
;
Wang, Yonghui
;
He, Yang
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2023/10/17
amphipathic peptides
cationic peptides
cell-penetrating peptides
cyclic peptides
hydrophobic peptides
polyarginines
Localized delivery of nanomedicine and antibodies for combating COVID-19
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 5, 页码: 1828-1846
作者:
Tu, Bin
;
Gao, Yanrong
;
An, Xinran
;
Wang, Huiyuan
;
Huang, Yongzhuo
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2023/10/17
SARS-CoV-2
COVID-19
Nanomedicine
Orally-inhaled delivery
Intranasal delivery
Antibody
Mannosylated engineered trichosanthin-legumain protein vaccine hydrogel for breast cancer immunotherapy
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 卷号: 223, 页码: 1485-1494
作者:
Chen, Guihua
;
Xiong, Wei
;
Gu, Zeyun
;
Gao, Yanrong
;
Hou, Jiazhen
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2023/10/17
Engineered protein
Hydrogel
Cancer vaccine
Trichosanthin
Legumain
Post-surgery
Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas
期刊论文
OAI收割
PHARMACEUTICS, 2022, 卷号: 14, 期号: 8, 页码: 12
作者:
Chang, Shih-Jen
;
Wang, Huiyuan
;
Chen, Jialin
;
Chen, Qianyi
;
Chang, Lei
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/09/30
infantile hemangioma
timolol maleate
butyryl timolol maleate
prodrug
sequelae
hydrolysis
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 7, 页码: 3187-3194
作者:
Tu, Bin
;
Wang, Huiyuan
;
An, Xinran
;
Qu, Jingkun
;
Li, Qianqian
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2024/03/21
SARS-CoV-2
Delta variant
Heparan sulfate
Spike protein
Heparin nanoparticle
Pulmonary delivery
Advances on Delivery of Cytotoxic Enzymes as Anticancer Agents
期刊论文
OAI收割
MOLECULES, 2022, 卷号: 27, 期号: 12, 页码: 35
作者:
Asrorov, Akmal M.
;
Muhitdinov, Bahtiyor
;
Tu, Bin
;
Mirzaakhmedov, Sharafitdin
;
Wang, Huiyuan
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2022/08/16
enzyme drugs
cancer therapy
trichosanthin
gelonin
peroxidase
glucose oxidase
asparaginase
exotoxin
diphtheria toxin
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 3, 页码: 1523-1533
作者:
Wu, Canhao
;
Xu, Qin
;
Wang, Huiyuan
;
Tu, Bin
;
Zeng, Jiaxin
  |  
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/06/15
SARS-CoV-2
COVID-19
Spike protein
Pseudovirus
Extracellular vesicles
ACE2
Intranasal administration
Neutralization